World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
31663
World Ranking
14471
National Ranking
7317

Ann D. Thor publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ann D. Thor sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 283 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ann D. Thor D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ann D. Thor sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ann D. Thor is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research primarily focuses on medical and molecular biological aspects of cancer, with a total of 22 publications in Medicine and 14 in Biochemistry, Genetics, and Molecular Biology.

The scientist's work extensively covers oncology, genetics, and molecular biology, reflecting in subfield contributions including:

  • Oncology
  • Genetics
  • Molecular Biology
  • Radiology, Nuclear Medicine and Imaging
  • Cancer Research

Main topics of research by Ann D. Thor include:

  • Cancer-related Molecular Pathways
  • Estrogen and related hormone effects
  • HER2/EGFR in Cancer Research
  • Monoclonal and Polyclonal Antibodies Research
  • Metabolism, Diabetes, and Cancer
  • Cancer Risks and Factors
  • Chronic Lymphocytic Leukemia Research

Ann D. Thor has published in several scientific journals with frequent contributions to:

  • Cancer Research
  • Cancer Drug Resistance
  • Molecular Therapy - Oncolytics
  • Breast Cancer Research
  • Clinical Cancer Research

Recent published papers include:

  • Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem, 2020, Cancer Drug Resistance
  • Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC, 2021, Molecular Therapy - Oncolytics
  • Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer, 2022, Breast Cancer Research
  • Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers, 2020, Clinical Cancer Research
  • HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel, 2023, Cancer Cell International

Frequent collaborators of Ann D. Thor include:

  • Bolin Liu
  • Reema S. Wahdan-Alaswad
  • Susan M. Edgerton
  • Sanbao Ruan
  • Hui Lyu

Best Publications

  • Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

    S. Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W. Bassett

  • Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

    Fitzgibbons Pl;Page Dl;Weaver D;Thor Ad

  • Prognostic Factors in Breast Cancer

    Patrick L. Fitzgibbons;Patrick L. Fitzgibbons;David L. Page;Donald Weaver;Ann D. Thor

  • Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

    Zhiqiang Zou;Anthony Anisowicz;Mary J. C. Hendrix;Ann Thor

  • c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

    Hyman B. Muss;Ann D. Thor;Donald A. Berry;Timothy Kute

  • Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

    Ann D. Thor;Dan H. Moore;Susan M. Edgerton;Ernest S. Kawasaki

  • Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

    Bryan P. Schneider;Molin Wang;Milan Radovich;George W. Sledge

  • Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas

    Guoren Deng;You Lu;Galina Zlotnikov;Ann D. Thor

  • HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

    Daniel F. Hayes;Ann D. Thor;Lynn G. Dressler;Donald Weaver

  • erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

    Ann D. Thor;Ann D. Thor;Donald A. Berry;Daniel R. Budman;Hyman B. Muss

  • ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.

    Olli-P. Kallioniemi;Anne Kallioniemi;Wayne Kurisu;Ann Thor

  • Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

    Irina N. Alimova;Bolin Liu;Zeying Fan;Susan M. Edgerton

  • Metformin induces unique biological and molecular responses in triple negative breast cancer cells.

    Bolin Liu;Zeying Fan;Susan M. Edgerton;Xin-Sheng Deng

  • Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.

    Dawn R Cochrane;Sebastián Bernales;Britta M Jacobsen;Diana M Cittelly

  • The art and science of cytopathology: Richard M. DeMay, MD. Chicago IL, ASCP Press, 1996, 2 vol set, 1,289 pages, $285

    Ann D Thor

  • Reconstitution of Caspase 3 Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin- and Etoposide-induced Apoptosis

    Xiao He Yang;Todd L. Sladek;Xuesong Liu;Bryn R. Butler

  • p53 gene mutations and protein accumulation in human ovarian cancer

    Jolanta Kupryjanczyk;Ann D. Thor;Roberta Beauchamp;Victor Merritt

  • Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.

    S.Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W Bassett

  • Expression of ras oncogene p21 in prostate cancer.

    Michael V. Viola;Frank Fromowitz;Sheila Oravez;Swati Deb

  • Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma

    Vincent L. Cryns;Ann Thor;Hong Ji Xu;Shi Xue Hu

Frequent Co-Authors

Jeffrey Schlom
Jeffrey Schlom National Institutes of Health
Dan H. Moore
Dan H. Moore University of California, San Francisco
Jennifer K. Richer
Jennifer K. Richer University of Colorado Anschutz Medical Campus
Donald A. Berry
Donald A. Berry The University of Texas MD Anderson Cancer Center
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor
David W. Yandell
David W. Yandell Harvard University
Larry Norton
Larry Norton Memorial Sloan Kettering Cancer Center
George W. Sledge
George W. Sledge Stanford University
Robert E. Scully
Robert E. Scully Harvard University
Kathy D. Miller
Kathy D. Miller Indiana University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine is just one pathway in the evolving healthcare landscape. There are a variety of related online degrees that open doors to rewarding roles in healthcare administration, leadership, pharmacy, and health information management.

For students interested in management positions, cheapest online mha programs can offer a flexible, affordable route to a Master of Healthcare Administration, equipping graduates with key leadership and organizational skills.

Nurses who seek to advance their careers can consider the cheapest dnp programs online, allowing them to earn a Doctor of Nursing Practice and prepare for roles in clinical leadership, academia, and advanced practice.

Those with an interest in pharmaceuticals can pursue a pharmacy degree online and gain vital knowledge for pharmacy practice and medication management careers.

Technology-focused students may opt for a bachelor of health information management online, preparing them to manage medical data and ensure healthcare information integrity.

Each pathway offers unique skills and career opportunities for those passionate about making a difference in healthcare.

Best Scientists Citing Ann D. Thor

Trending Scientists

Recently Published Articles